MARKET

SLP

SLP

Simulations Plus Inc
NASDAQ
15.37
+0.26
+1.72%
After Hours: 15.37 0 0.00% 17:36 05/22 EDT
OPEN
15.13
PREV CLOSE
15.11
HIGH
15.59
LOW
15.13
VOLUME
171.31K
TURNOVER
--
52 WEEK HIGH
34.01
52 WEEK LOW
11.09
MARKET CAP
310.56M
P/E (TTM)
-4.9211
1D
5D
1M
3M
1Y
5Y
1D
Simulations Plus CEO joins Craig-Hallum Institutional Investor Conference for one-on-one meetings
PUBT · 1d ago
Simulations Plus to Participate in the 23rd Annual Craig-Hallum Institutional Investor Conference
Barchart · 1d ago
Weekly Report: what happened at SLP last week (0511-0515)?
Weekly Report · 5d ago
Weekly Report: what happened at SLP last week (0504-0508)?
Weekly Report · 05/11 09:47
Simulations Plus, Nvidia collaborate to scale AI-assisted modeling workflows
TipRanks · 05/07 06:33
Simulations Plus Collaborates With Nvidia During AI Drug Modeling Push
Benzinga · 05/06 15:50
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 05/06 12:06
Simulations Plus Partners With Nvidia Over GPU-Accelerated Simulation, AI-Assisted Workflows For Computationally Intensive Modeling Applications Within The Drug Development Lifecycle
Benzinga · 05/06 11:56
More
About SLP
Simulations Plus, Inc. specializes in model-informed and artificial intelligence (AI)-accelerated drug development. The Company helps its clients by accelerating the discovery, development, and commercialization of pharmaceuticals and other products through science-based software and consulting solutions. The Company’s segments include Software and Services. The Company's Software segment supports pharmaceutical research, development, and commercialization through simulation, modeling, and AI-driven prediction. Its main products include GastroPlus, ADMET Predictor, MonolixSuite, and others for disease modeling and training, as well as Pro-ficiency for clinical operations. Its Services segment includes advanced consulting services across the entire drug development lifecycle. Its scientists and engineers specialize in drug discovery, pharmacokinetics, pharmacodynamics, drug modeling, clinical trial data analysis, regulatory strategy, and medical communications.

Webull offers Simulations Plus Inc stock information, including NASDAQ: SLP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SLP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SLP stock methods without spending real money on the virtual paper trading platform.